GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Blueprint Medicines Corp (LTS:0HOJ) » Definitions » Dividend Yield %

Blueprint Medicines (LTS:0HOJ) Dividend Yield % : 0.00% (As of Jun. 19, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Blueprint Medicines Dividend Yield %?

As of today (2024-06-19), the Trailing Annual Dividend Yield of Blueprint Medicines is 0.00%.

The historical rank and industry rank for Blueprint Medicines's Dividend Yield % or its related term are showing as below:

LTS:0HOJ's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.64
* Ranked among companies with meaningful Dividend Yield % only.

Blueprint Medicines's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00.

As of today (2024-06-19), the Forward Dividend Yield % of Blueprint Medicines is 0.00%.

Blueprint Medicines's Dividends per Share for the three months ended in Mar. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Blueprint Medicines Dividend Yield % Historical Data

The historical data trend for Blueprint Medicines's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueprint Medicines Dividend Yield % Chart

Blueprint Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Blueprint Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Blueprint Medicines's Dividend Yield %

For the Biotechnology subindustry, Blueprint Medicines's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blueprint Medicines's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Blueprint Medicines's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Blueprint Medicines's Dividend Yield % falls into.



Blueprint Medicines Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Blueprint Medicines  (LTS:0HOJ) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Blueprint Medicines Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Blueprint Medicines's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Blueprint Medicines (LTS:0HOJ) Business Description

Traded in Other Exchanges
Address
45 Sidney Street, Cambridge, MA, USA, 02139
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants.

Blueprint Medicines (LTS:0HOJ) Headlines

No Headlines